Where markets meet medicine; a biotech entrepreneur at the tip of the spear

If billionaire “prospector” Mark Creasy has the Midas touch when it comes to divining lucrative mineral deposits, Paul Hopper just might be the man who wields the mythical rod of Asclepius - the Greek God of medicine - when it comes to the equally lucrative ASX-listed biotechnology space. By any measure Hopper has experienced success listing and developing biotech companies on

Related Keywords

United Kingdom ,China ,Germany ,Australia ,United States ,Greece ,Australian ,America ,Greek ,Chinese ,Aussie ,Radiopharm Theranostics ,Paul Hopper ,Hopper Imugene ,Sloan Kettering ,Mark Creasy ,Imugene Ltd ,Telix Pharmaceuticals ,Viralytics Ltd ,Patrys Ltd ,Newcastle University ,Pfizer ,Pharmaceuticals Biotechnology ,Greek God ,Chimeric Therapeutics ,Arovella Therapeutics ,Prescient Therapeutics ,Scientificallyi M ,Executive Chairman ,Memorial Sloan Kettering ,Radiopharm Therapeutics ,